Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

M1 FMK > Pharmicokinetics > Flashcards

Pharmicokinetics Flashcards

1
Q

Specificity

A

The drug only produces one effect on the body if it is very specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Selectivity

A

Drugs prefers to bind to one specific target (receptor) over others, most drugs are selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Agonist

A

Drugs fits the receptor and activates it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antagonist

A

The drugs fits the receptor but doesn’t activate it, just prevents its activation by another molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What class of drugs have efficacy?

A

Agonists (efficacy is the ability to produce an effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Law of mass action

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Affinity

Relationship to Kd

A

1/KD

From law of mass action plot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

KD

Definition

A

The drug concentration needed for 50% of receptors to be bound by the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Potency

A

Used to compare binding affinities of drugs that bind to the same receptor site and work by the same mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inverse agonists

A

Produce the opposite effect as the agonist. They still activate the receptor but instead of triggering a positive response, they cause a negative one.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dose response curves for different types of agonists

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Competitive antagonists

A

Bind to the same site on the receptor as the agonist

Can be overcome by increasing concentration of agonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Non-competitive antagonist

A

Bind to a different site on the receptor than where the agonist binds, but still prevent the agonist from activating the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Irreversible antagonists

A

Bind permanently to the receptor, often by forming covalent bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A

X - agonist alone

Y - agonist with competitive antagonist

Z - agonist with an irreversible antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Quantal dose-response curves

A

Used to study how drugs affect a population - aka “all-or-none” curves = measure whether a drug causes a specific effect (yes or no) in a population of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cumulative frequency distribution

A

Used to determine ED50 and TD50

When drugs TD50/ED50 <10 we say that the drug has a “narrow” therapeutic index - there is a small variation in drug dosage that causes desired effect vs. harmful effects

For humans we use TD50 (toxic dose in 50% of population)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

NSAIDs

A

Competitively bind cyclooxygenase (COX) preventing arachidonic acid from binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Aspirin

A

Non-competitively binds COX receptors (also irreversibly acetylates the enzyme) which prevents arachidonic acids from every binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Gs proteins

A

Stimulate adnylyl cyclase - increases cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Gi proteins

A

Inhibit adenylyl cyclase - reduces cAMP, often resulting in hyperpolarization of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Gq proteins

A

Activate a different pathway using diacyglycerol (DAG) and inositol triphosphate (IP3) as second messengers. Typically when this pathway is activated there is an increase of calcium levels inside cells. When intracellular calcium levels increase, this can promote cell depolarization, release of neurotransmitters, or contraction depending upon the cell type.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When receptors are exposed to continuous stimulation:

A

Desensitization - often because the receptors uncouple from their G-proteins

Down-regulate - few receptors available on the cell surface

Tachyphylaxis - decrease the situation in which there is a rapid or substantial decrease in the effect of a drug over time

(from AI - rapidly diminishing response to successive doses of a drug, rendering it less effective. The effect is common with drugs acting on the nervous system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What may occur when receptors are continuously blocked by an antagonist?

A

The receptors may become supersensitized and up-regulate making the cell more responsive to stimulation when the antagonist dissociates (or competitively displaced)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Autoreceptors

A

Located on the presynaptic neuron

Limits the release of neurotransmitters

Drugs that act on autoreceptors can affect the amount of neurotransmitter reaching the postsynaptic neuron (leads to either up/down regulation - depending on whether drug is agonist/antagonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Absorption

A

The process of moving a drug from its site of administration into the bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

PO absorption

A
  1. Absorbed in the gut
  2. Travels to the liver via the portal vein
  3. First-pass effect in the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Bioavailability

A

(F) - fraction (or percentage) of the drug that makes it into systemic circulation after the first-pass through the liver (i.e 40% of a drugs ia metabolized by first-pass metabolism, leaving 60% bioavailable - F=0.6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What enteral ROA(s) bypass the liver and avoid the first-pass effect?

A

Sublingual and rectal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Parenteral routes

A

All routes that do not involve the GI tract - IV, inhalation, transdermal…etc.

Also bypasses first-pass metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Hydrophilic drugs

A

Need to be small enough to pass through aquaporins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

P-glycoprotein

A

Work to efflux drugs from cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

OATP1B1 and OATP1B3

A

Help transport drugs into cells

34
Q

Breast Cancer Resistance Protein

A

Pumps drugs out of cells

35
Q

Organic cation transporters and multidrug and toxin extrusion proteins

A

Move drugs in and out of renal cells

36
Q

Factors affecting absorption

A
  1. Drug size
  2. Formulation (i.e. tablet, capsule)
  3. pka
  4. pH of surrounding environment
  5. Dose administered and resulting concentration gradient
  6. Surface area and blood flow at absorption site
37
Q

Apparent volume of distribution (Vd)

A

Helps estimate how much of the drug is found in different areas (compartments) of the body.

Vd assumptions: drugs is distributed equally throughout all body compartments and instantaneous distribution

Vd = Dose/C0

C0 represents the drug’s inital concentration in plasma.

38
Q

Properties that help drugs cross BBB and/or placental barrier

A
  1. Low-ionization
  2. High lipophilicity
  3. Low amount of non-specific protein binding to ablumin
  4. Small size

If small enough (~equal to the mw of water) then things molecules will readily diffuse through the barrier with water, regardless of ionization state

39
Q

Enterohepatic recirculation

A

Acts like a resevoir for the drug

After being metabolized by the liver, some drugs are excreted into the bile and then passed back into the instestines. Under favorable conditions, the drug may be reabsorbed from the intestines back into the bloodstream, extending its time in the body

Estrogens (i.e. oral contraceptives) undergo enterohepatic recirculation - helps maintain their levels in body.

40
Q

Infants

Impact of age on drug absorption/distribution

A

Have higher levels of extracellular fluid compared to adults, which can change the distribution and plasma concentration of some durgs

41
Q

Older adults

Impact of age on drug absorption/distribution

A

Typically have more body fat than younger people, which can affect how fat-soluble drugs are stored and released

Also tend to have less p-glycoprotein activity at the BBB, so more drugs may enter the CNS

42
Q

Main goal of biotransformation

A

To make drugs more water-soluble - allowing them to be more easily removed from the body

43
Q

Phase 1 rx’ns

A

Include oxidation, reduction, and hydrolysis

Often referred to as unmasking or non-synthetic reactions because they expose or add a functional group to the drug, but they do not involve combining 2 large molecules to make a new one

44
Q

Phase 2 rx’ns

A

Involve conjugation - and are sometimes called synthetic rx’ns

Combine the drug with another molecule like glucoronic acid, sulfate, or glutathione to form a new, more water-soluble compound

45
Q

Oxidation of phase 1 rx’ns

A

Most common type of phase 1 rx’n

Often carried out by specific enzymes call ctyochrome P450 (CYP) enzymes in the liver

46
Q

P450 inhibitors

A

Cimetidine (OTC histamine-2 receptor antagonist), “azole” antigungals, some HIV medications

47
Q

P450 inducer

A

Increases the activity of the CYP enzyme, causing more enzyme to be made or stabilizing the mRNA that encodes for the enzyme.

Leads to faster breakdown of other drugs that are metabolized by the same enzyme, may reduce other drug’s effectiveness.

Antiepileptic meds (carbamazepine, phenobarbital, phenytoin) and rifampin are potent P450 inducers

48
Q

Hydrolysis rx’sn

A

Peptidases/esterases/amidases

Phase 1 rx’sn

49
Q

Glucoronidation

A

Glucuronyl transferase adds glucoronic acid to the drug, making it easier to excrete

Infants under 1 y/o have immature glucuronidation capabilities, and toxicities can result

Phase 2 rx’ns

Some drugs that are glucuronidated are excreted into bile and can undergo enterohepatic recirculation

50
Q

Glutathione conjugation

A

A small peptide added to detoxify harmful drug metabolites

Phase 2 reactions

51
Q

Phase 2 rx’ns

A

Sulfation, acetylation, and methylation

Along with glutathione conjugation and glucuornidation

52
Q

Two pathways of drug elimination

A

Metabolism - drug is chemically altered (mainly liver) and excretion (mainly kidneys)

53
Q

Drug clearance

A

Refers to the volume of fluid (usually plasma) from which a drug is completely removed over a given period of time - mL/min

54
Q

What factors influence hepatic clearance?

A

Factors that influence:
1. Enzyme induction or inhibition
2. Liver blood flow
3. Protein binding

55
Q

Renal clearance

Equation

A

CIrenal = UV/P

U = concentration of drug in urine

V = urine volume formed per minute

P = concentration of drug in plasma

56
Q

Main processes of renal clearance

A

Glomerular filtration - passive procces where small, unbound drugs are filtered from the blood into the renal tubule (creatinine clearance used to estimate kidney function)

Active secretion - some drugs are actively transported from the blood into the urine using ATP. Involves protein carriers, which can be saturated and lead to drug interactions

Reabsorption - drugs that are lipid-soluble can passively diffuse back into the bloodstream from the renal tubules. However, polar or ionized drugs are more likely to stay in the urine and be excreted.

Making urine more acidic (with Vit C) or more alkaline (NaHCO3) can help excrete certain drugs faster by preventing their reabsorption

57
Q

Gray baby syndrome

A

Due to immature hepatic enzymes needed for glucoronidation of chloramphenicol

57
Q

Antagonism

Drug interactions

A

Pharmcologically: at the receptor level, where two drugs compete for the same receptor

Physiologically: When drugs act through different body systems but have opposing effects

Chemically: two drugs form a chemical complex

58
Q

Synergism

Drug interactions

A

Combining antigoagulants and antiplatelets can increase overall blood-thinning effects

59
Q

Pharmacokinetic drug interactions

A

Absorption: one drug can interfere with the absorption of another, either by altering the stomach’s pH or forming complexes that reduce absorption

Distribution: Drugs can compete for binding sites on proteins like albumin, affecting how much of each drug is “free” to act in the body

Metabolism: some drugs speed up or slow down liver enzymes - this can lead to one drug being metabolized too quickly or slowly

Elimination: drugs can affect each other’s clearance, especially through the kidneys, either by competing from transport proteins or altering pH of urine

60
Q

Time-response curves

A

Useful for calculating bioavailability

Area under the curve represents total drug exposure over time

61
Q
A
62
Q
A
63
Q

Zero-order elimination kinetics

A

Alcohol is the key example

Enzyme(s) responsible for eliminating drugs are sturable (i.e. alcohol DH)

64
Q

First-order elimination kinetics

A

Applies to most drugs

Rate of elimination is proportional to the drug concentration

A constant fraction of the drug is eliminated per unit of time - rate of elimination depends on how much drug is in the body

65
Q

Calculation of Vd

A
66
Q

Formula for calculating steady-state concentration

A

Cpss = MD/Cl

MD = the maintenance dose

Cl = clearance

67
Q

How long does it take to reach steady state plasma concentration?

A

4-5 half lives if a drug is administered once every half-life

This is regardless of ROA

Once steady state is achieved it takes 4-5 half-lives to completely clear the drug from the body

68
Q

How to calculate the elimination constant

A
69
Q

One vs. two compartment models

A
70
Q

Calculate bioavailability of oral drug

A

F = AUCoral/AUCIV

71
Q

What increases serum concentration fluctuation?

A

Extended dosing intervals

Cl = clearance

72
Q

Most drugs gain entry into cells by?

A

1.Passive diffusion with zero order kinetics
2.Passive diffusion with first order kinetics
3.Active transport with zero order kinetics
4.Active transport with first order kinetics
5.Passive diffusion through membrane pores

73
Q

Elimination half-life

A

t1/2 = 0.692 (Vd)/Cl

Vd = L

Cl = mL/min.

74
Q

An elderly patient is prescribed a beta receptor antagonist to treat his atrial fibrillation. These drugs act at post-synaptic receptors of the heart. Which of the following changes do you expect within the first 2 weeks of therapy?

A

Beta-receptor numbers increase

75
Q

Which of the following provides information about the variation in sensitivity to a drug within a population being studied?

A

Quantal dose-response curves

76
Q

Which of the following is correct about the concept of volume of distribution?

A

This is a value that remains relatively constant in a specific person who is taking a specific drug.

77
Q

Which of the following processes accounts for MOST movement of drugs across biological barriers?

A

Passive diffusion

78
Q
A
78
Q

Efficacy vs. potentcy

A

Efficacy - considers response

Potency - considers binding affinity

79
Q

What aspect of the cell contains steroid receptors?

A

Cytoplasm, receptor is then translocated into the nucleus

M1 FMK (55 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions